Literature DB >> 25329109

Prenatal diagnosis and perinatal outcome in congenital diaphragmatic hernia. Single tertiary center report.

Stefania Tudorache1, Luminiţa Cristina Chiuţu, Dominic Gabriel Iliescu, Raluca Georgescu, George Alin Stoica, Cristiana Eugenia Simionescu, Eugen Florin Georgescu, Răducu Nicolae Nemeş.   

Abstract

PURPOSE: To evaluate the perinatal results for fetuses and neonates with left-sided congenital diaphragmatic hernia (CDH) and the role of the prenatal diagnosis in the pregnancy outcome.
MATERIALS AND METHODS: We reviewed data from fetuses and neonates with left-sided CDH, managed from January 2009 and December 2013 in the University Clinic Hospital, Craiova, Romania. The following data were analyzed: the gestational age at the time of diagnosis, fetal karyotyping, presence of associated structural malformations, ultrasound (US) data (circumference and area of right lung, lung-to-head ratio - LHR, observed/expected LHR, hepatic herniation), the type of antenatal care, the pregnancy outcome, the place of birth and the conventional autopsy data, if performed. Perinatal outcomes were obtained by reviewing hospital documents.
RESULTS: Twenty-one cases were identified. No fetal surgery was performed in our series. Mean gestational age at time of diagnosis was 29 weeks of amenorrhea (WA) (range, 16-37 WA). Associated structural malformations were noticed in nine (42.8%) cases, in which three fetuses had a normal karyotype and two had chromosomal abnormalities, and four fetuses were not investigated. Isolated congenital diaphragmatic hernia was confirmed in 12 (57.1%) cases. All early second trimester diagnosed cases were terminated. The overall mortality rate was 61.9%. Rates of fetal deaths, early neonatal deaths, late neonatal deaths, and survival were 28.5%, 19%, 14.2%, and 38%, respectively. The perinatal mortality rate was 19% in cases with isolated congenital diaphragmatic hernia.
CONCLUSIONS: The overall and perinatal mortality rate in congenital diaphragmatic hernia was still high in our series. Early perinatal deaths are associated with early diagnosis and with the presence of other structural defects. The prevalence of chromosomal abnormalities in perinatal death could not be determined from these data. In isolated congenital diaphragmatic hernia, mortality is related to the presence of herniated liver and severe pulmonary hypoplasia, this being well correlated with antenatal ultrasound parameters used for the estimation of fetal lung volumes. The antenatal diagnosis allowed better counseling of the parents, description of associations and improving the neonatal care.

Entities:  

Mesh:

Year:  2014        PMID: 25329109

Source DB:  PubMed          Journal:  Rom J Morphol Embryol        ISSN: 1220-0522            Impact factor:   1.033


  4 in total

1.  Primary Combined Latissimus Dorsi and Serratus Anterior Flap Repair of Right-Sided Congenital Diaphragmatic Agenesis in a Neonate.

Authors:  Madan Samuel; Rajiv Parapurath
Journal:  Sultan Qaboos Univ Med J       Date:  2016-02-02

2.  Investigating the use of ultrasonography for the antenatal diagnosis of structural congenital anomalies in low-income and middle-income countries: a systematic review.

Authors:  Stephanie Michele Goley; Sidonie Sakula-Barry; Nana Adofo-Ansong; Laurence Isaaya Ntawunga; Maame Tekyiwa Botchway; Ann Horton Kelly; Naomi Wright
Journal:  BMJ Paediatr Open       Date:  2020-08-20

3.  Possible Prevention of Neonatal Death: A Regional Population-Based Study in Japan.

Authors:  Shigeki Koshida; Takahide Yanagi; Tetsuo Ono; Shunichiro Tsuji; Kentaro Takahashi
Journal:  Yonsei Med J       Date:  2016-03       Impact factor: 2.759

4.  Prognostic factors of death in children during the first year of life due to congenital diaphragmatic hernia: analysis of a hospital cohort from 2005 to 2015.

Authors:  Roberta Ivanira Silva do Carmo; Fernando Maia Peixoto-Filho; Arnaldo Bueno; Marlon Fonseca; Saint Clair Dos Santos Gomes Junior
Journal:  J Pediatr (Rio J)       Date:  2019-04-25       Impact factor: 2.990

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.